摘要
目的分析比较国产与进口罗红霉素治疗呼吸道感染的经济效果。方法选取2013年1月至2013年12月期间在我院接受治疗的呼吸道感染患者80例,并将其随机分为A、B两组。A组服用国产罗红霉素,每次150 mg,每日2次;B组服用进口罗红霉素,每次150 mg,每日2次。两组患者均服用7-14 d后以药物学中成本-效果分析法对两组患者的经济效果进行分析。结果两组患者在临床有效率、不良反应发生率等指标上无显著差异,而国产罗红霉素总体治疗成本明显低于进口罗红霉素,组间存在显著差异（P〈0.05）。结论国产与进口罗红霉素对呼吸道感染均具有较好的临床效果,但从经济角度看来,可选择国产罗红霉素进行治疗。
Objective To analysis of domestic and imported luo erythromycin economic effect for the treatment of respiratory tract infection. Methods 80 patients with respiratory tract infection were randomly divided into two groups A and B. Taking domestic luo erythromycin group A and group B taking import luo erythromycin. Results Two groups of patients in the clinical efficient and incidence of adverse reactions such as indicators, there is no significant difference of general and homebred ROM erythromycin treatment costs significantly lower than the imported luo erythromycin （P〈0.05）. Conclusion Domestic and imported luo erythromycin on respiratory tract infection have good clinical effect, but from an economic point of view, can choose domestic luo erythromycin treatment.
出处
《中国卫生标准管理》
2015年第4期124-125,共2页
China Health Standard Management
关键词
国产
进口
罗红霉素
呼吸道感染
经济效果
Domestic
Imports
ROM erythromycin
Respiratory tract infections
The economic effect
